Thursday, August 1, 2019

Zydus completes phase III trials of Diabetes drug in India: Company

Zydus completes phase III trials of Diabetes drug in India: Company "The trial was a multi-centric, randomised, double blind study to evaluate the safety and efficacy of 2mg and 4mg of Saroglitazar compared to Pioglitazone 45mg in patients with type 2 Diabetes Mellitus.

from Moneycontrol Business News https://ift.tt/2Kxa80H
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

What made Putin sell 22,000 kg gold from Russia this year?

Russia’s central bank has sold 21.8 tonnes or 22,000 kilograms of gold so far in 2026 to help fund the country’s widening budget deficit, wh...